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A Comparison of In Vivo 13C MR Brain Glycogen
Quantification at 9.4 and 14.1 T
Ruud B. van Heeswijk,1* Yves Pilloud,1 Florence D. Morgenthaler,1 and Rolf Gruetter1–3
The high molecular weight and low concentration of brain gly-
cogen render its noninvasive quantification challenging.
Therefore, the precision increase of the quantification by
localized 13C MR at 9.4 to 14.1 T was investigated. Signal-to-
noise ratio increased by 66%, slightly offset by a T1 increase
of 332 6 15 to 521 6 34 ms. Isotopic enrichment after long-
term 13C administration was comparable (~40%) as was the
nominal linewidth of glycogen C1 (~50 Hz). Among the factors
that contributed to the 66% observed increase in signal-to-
noise ratio, the T1 relaxation time impacted the effective sig-
nal-to-noise ratio by only 10% at a repetition time 5 1 s. The
signal-to-noise ratio increase together with the larger spectral
dispersion at 14.1 T resulted in a better defined baseline,
which allowed for more accurate fitting. Quantified glycogen
concentrations were 5.8 6 0.9 mM at 9.4 T and 6.0 6 0.4 mM
at 14.1 T; the decreased standard deviation demonstrates the
compounded effect of increased magnetization and improved
baseline on the precision of glycogen quantification. Magn
Reson Med 67:1523–1527, 2012. VC 2011 Wiley Periodicals, Inc.
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INTRODUCTION
Glycogen (Glyc) is a branched polysaccharide chain of
glucosyl units and the main form of energy storage in
the brain (1). Glycogen has much lower concentrations
in the brain than in tissues such as the liver and muscles
(on the order of 5 mM vs. >100 mM in the liver) (2),
which until recently caused its importance as a cerebral
energy store to be largely neglected. Furthermore, besides
brain energy homeostasis, brain glycogen has been linked
to memory formation (3) and neurotransmitter synthesis
(4), while its turnover has also been shown to change
under physiological changes such as mild sleep depriva-
tion (5) and lithium treatment (6). Therefore, the precise
metabolic role of brain glycogen remains to be fully elu-
cidated (1).
To date, 13C localized nuclear magnetic resonance
(NMR) in combination with 13C label incorporation
through a substrate such as [1-13C] glucose (Glc) (7) is
the only method to study brain glycogen metabolism
noninvasively in vivo. Several 13C NMR methods have
been proposed to quantify its concentration (8–10), but
these remain challenging and time consuming, not only
due to the low amount of signal per unit of time caused
by the carbon nucleus and glycogen concentration but
also due to its polysaccharide structure. This latter chal-
lenge expresses itself as short T1 and T2 relaxation times
(on the order of a few hundred and 5–10 ms, respec-
tively; Ref. 11), caused by long correlation times. The
Glyc C1 resonance is located next to those of Glc C1b
and C1a (100.5, 96.6, and 92.7 ppm, respectively), which
makes the three resonances straightforward to detect at
the same time, but which may hamper their peak fitting.
All of the above limitations (low relative signal, broad
linewidth, and short relaxation times) change with mag-
netic field strength; an increase in magnetic field
strength might thus have a compounded beneficial effect
on the complicated quantification process. Therefore, the
aim of this study was to estimate the potential improve-
ments in the quantification of the Glyc C1 resonance
when the magnetic field strength B0 was increased from
9.4 to 14.1 T.
MATERIALS AND METHODS
To quantify brain glycogen, 13C localized NMR spectros-
copy was performed using two horizontal bore animal
MR scanners (Agilent Technologies, Santa Clara, CA): an
actively shielded 9.4 T/31 cm magnet and a 14.1 T/26 cm
magnet. Both magnets were equipped with 12-cm inner-
diameter gradient sets that allowed a maximum gradient
strength of 400 mT/m in 120 ms. All experimental condi-
tions for glycogen quantification in the two MR scanners
were identical, except when specified otherwise.
In both magnets, a 14-mm quadrature 1H coil with a
single three-loop 10-mm diameter 13C coil (12) was used
for transmission and reception. As the signal-to-noise ra-
tio (SNR) of a coil is proportional to the square root of
its quality (Q)-factor: SNR  Q0.5 (13), the loaded Q fac-
tors of these coils were determined on a network ana-
lyzer (Agilent Technologies); loading the coil was done
by placing it on top of a 50-mL tube filled with 500 mM
NaCl. The Q factor was then approximated as its reso-
nance frequency divided by the full width at half maxi-
mum of the tuned and matched resonance (i.e., f0/Df)
detected by a sniffer loop. Noise figures for the receive
chains of both scanners were also obtained with a noise
diode (Micronetics, Hudson, NH).
All animal experiments were conducted according to
local guidelines after obtaining approval from the local
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animal ethical committee. Male Sprague–Dawley rats
(220 g, n ¼ 4 at 9.4 T, n ¼ 3 at 14.1 T, Charles River
Laboratories, L’Arbresle, France) were prelabeled at the
Glyc C1 position as previously described (9), such that
the Glyc C1 isotopic enrichment (IE) was high (40%)
and constant. Briefly, two evenings before the experi-
ments, rats were fasted overnight to minimize endoge-
nous unlabeled liver Glyc stores. The following morning,
24 h before the experiments, the rats were given 10% w/
v [1-13C] Glc (IE ¼ 99%, Cambridge Isotope Laboratories,
Andover, MA) in tap water solution ad libitum as their
only source of food and water, which would allow the
glycogen IE to reach an empirically established steady
state of 35–45% (9).
Before placing the animals in the magnet, they were
anesthetized with isoflurane (5% for induction and 1.8–
2.0% for maintenance) in a 70:30 mixture of nitrous oxide
and oxygen. After intubation and initialization of assisted
breathing, a femoral artery was catheterized for blood
sampling and a femoral vein was catheterized for infusion
of a-chloralose (Acros Organics, Geel, Belgium) and 20%
w/v [1-13C] Glc in saline. This Glc infusion was initially
set at 40% IE through mixing of 99% [1-13C] Glc with
nonlabeled Glc to reflect the previously mentioned steady
state Glyc IE. The infusion rate was approximately 0.2
mg Glc/h to maintain constant euglycemia. After surgery,
isoflurane was turned off and replaced by a-chloralose
alone (26.7 mg/kg/h). Blood samples were taken every 30
min for blood gas and glucose analysis, which were used
for according adjustments of the respiration volume and
frequency (pCO2 ¼ 39 6 2 mmHg, pO2 > 100 mmHg, pH
¼ 7.41 6 0.03, [blood Glc] ¼ 7 6 1 mM). Temperature
and breathing were monitored through a rectal probe and
respiration pillow, respectively. A silicon tube with circu-
lating warm water was placed on the body of the animal
to maintain constant body temperature (T ¼ 37.7 6 0.2C)
through a feedback loop. The radiofrequency coil was
then carefully positioned such that it just touched the top
of the rat head (i.e., <0.5 mm distance from the top of the
head for the entire 13C loop) to optimize the use of the
sensitive volume of the coil. The animal was then
inserted into the MR scanner.
After FASTMAP (14) shimming (resulting in a 22 and
26 Hz water linewidth at 9.4 and 14.1 T, respectively, for
a large 6  8  10 mm3 voxel in the brain), the IE of
N-acetyl aspartate (NAA) was determined with a carbon-
edited 1H STEAM sequence, which was used to calculate
the IE of brain Glyc C1 as described previously (9). In
short, this sequence uses a 13C inversion pulse in the
middle STEAM period to invert the 13C-coupled NAA
C6 resonances every other acquisition through their J-
coupling, which through subtraction edits for the 13C-
coupled resonances to determine the 13C-NAA/[NAA] ra-
tio. Previous studies (9) have shown that under these ex-
perimental conditions the in vivo Glyc C1 IE is 2.2
times this NAA IE under these experimental conditions.
To keep the Glyc enrichment percentage constant, the IE
of the Glc infusion was changed accordingly.
Localized 13C spectroscopy was performed on a 6  8
 10 mm3 voxel with a modified SIRENE pulse sequence
(15), which consisted of 3D outer volume suppression,
1D inversion nulling, and an added 1D Image-Selected
In vivo Spectroscopy (ISIS) module (16). Bilevel Waltz-
16 nuclear Overhauser effect (NOE) and decoupling were
applied at the Glyc/Glc 1H frequency. The SNR of this
volume was determined for nine batches of 4096 acquisi-
tions (repetition time [TR] ¼ 1 s; total time 1 h 9 min) as
the peak height divided by the root mean square of the
noise after applying two times zero filling and 15 Hz
line broadening. To determine the differences in T2*
between the different field strengths, the linewidth of
the Glyc resonance was determined by taking the full
width at half maximum in these processed spectra and
subtracting the 15 Hz line broadening. The NOE factor
was determined in two animals at each field strength by
also acquiring a similar batch with the NOE turned off
and dividing the Glyc C1 peak integral of the batch with
NOE by that of the batch without NOE.
To assess the T1 of brain and equivalent (8,17) muscle
glycogen, an unlocalized inversion recovery pulse
sequence consisting of an 8 ms adiabatic inversion pulse
and an adiabatic excitation pulse was applied (in n ¼ 2
animals at each magnetic field strength). The inversion
time (TI) was varied in 11 steps from 1 ms to 7 s. The T1
relaxation time was determined by fitting the signal in-
tensity S with the three-parameter equation S(TI) ¼ Sss(1
 bexp(TI/T1)) in OriginPro (OriginLab Corp, Northamp-
ton, MA). Here Sss is the steady state signal and b is a
correction factor for taking incomplete inversion into
account.
The rat was then replaced with a phantom containing
5 mM [1-13C] Glc and 500 mM oyster Glyc (Sigma-
Aldrich, St. Louis, MO) to calculate their absolute con-
centrations as described previously (9,10). Briefly, the
three peaks of interest (Glyc C1 as well as the a and b
conformation of Glc C1) were fitted through deconvolu-
tion with a gaussian curve using built-in scanner soft-
ware (Agilent Technologies, Santa Clara, CA) to deter-
mine their signal intensity S. The Glyc C1 signal and the
sum of the Glc C1a and C1b integrals were then used to
determine the total brain Glyc and Glc concentrations, as
follows:
G½ iv¼
SG;iv
SG;ph
SFA;iv
SFA;ph
a
IEG;ph
IEG;iv
G½ ph; ½1
where G is Glc or Glyc, iv stands for in vivo, ph stands
for phantom, FA is the formic acid reference bulb (used
to correct for differences in coil loading), and a ¼ 0.98 is
a factor to compensate for differences in T1 and NOE
between rat brain and oyster glycogen (equal to 1 for
Glc). The resulting Glyc time courses were subjected to a
standard Fisher F-test to determine if the hypothesis that
the slope was zero could be rejected (18). This was
accomplished from a linear fit of the time course and
determining if a/sa > qt0.05,7, where a is the slope of the
linear fit, sa the standard deviation of this slope, and
qt0.05,7 ¼ 1.895 the 95% confidence quantile of the Stu-
dent’s t-test for the used number of degrees of freedom.
RESULTS
To account for the differences in quality between the ra-
diofrequency coils used at the different magnetic field
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strengths, their loaded Q factors were determined on a
network analyzer. At 14.1 T, Q ¼ 67 6 3, while at 9.4 T
Q ¼ 63 6 3. The ratio of these loaded Q factors, which
might have an influence on the SNR ratio between the
two magnetic field strengths, was therefore 1.06. The
noise figures of the 9.4 and 14.1 T scanners were 1.31
and 1.23 dB, respectively, resulting in a noise amplifica-
tion of 1.16 and 1.15 and thus a factor 0.99 influence on
the SNR ratio.
To enhance the 13C NMR signal, the animals were
prelabeled at the Glyc C1 position. The IE of Glyc C1 as
determined from the IE of NAA was similar at both field
strengths (39 6 5% for n ¼ 4 animals at 9.4 T and 36 6
4% for n ¼ 3 animals at 14.1 T, see Table 1). During the
subsequent series of localized MR measurements (1 h 9
min per time point), the Glyc C1 resonance was consis-
tently detected with high SNR of 6–14 (Fig. 1). The line-
widths of the Glyc C1 resonance after shimming were
similar and consistent at both field strengths (48 6 8 Hz
at 9.4 T and 53 6 9 Hz at 14.1 T). As the inverse of these
linewidths divided by p, the T2* relaxation times, there-
fore, were estimated at 6.6 6 1.1 and 5.9 6 1.0 ms at 9.4
and 14.1 T, respectively. For the convenience of discus-
sing the SNR differences found in the study, the relative
SNR, rSNR ¼ SNR14.1 T/SNR9.4 T is introduced here; for
Glyc C1, rSNR ¼ 1.7 versus 1.5 for Glc C1b (Table 1),
while the distance of the coil from the top of the rat
head was the same within 0.5 mm and the same volume
of interest (480 mL) was used. The Glyc C1 NOE amplifi-
cation factor was 2.8 6 0.1 at both field strengths.
The increased SNR together with the increased spec-
tral dispersion and similar linewidths thus resulted in a
more defined spectral baseline at 14.1 T: the resonances,
including Glyc, were narrower (in ppm) and thus a
wider and relatively flatter baseline between the resonan-
ces was apparent (Fig. 1). This allowed for more robust
spectral peak fitting, which in turn allowed for a more
accurate quantification through Eq. 1, as evidenced in
the halving of the error of the calculated concentration
of Glyc at 14.1 T compared to 9.4 T. The quantified brain
Glyc time courses clearly demonstrate this improved
quantification (Fig. 2): under the same physiological and
equipment conditions, the Glyc time courses of the indi-
vidual animals at 9.4 T as measured with the SIRENE
sequence (Fig. 2a) have a visibly higher spread than
those at 14.1 T (Fig. 2b).
The F-tests to determine the significance of the slope of
the time courses at both magnetic field strengths resulted
in ratios a/sa of the slope of the linear fit and its standard
deviation that ranged from 0.08 to 1.04. These were all
lower than the quantile qt0.05,7 ¼ 1.895, which signified
that the hypothesis that the slope was zero could not be
rejected. This then meant that no significant increase or
decrease of the glycogen concentration over time could be
detected within the individual animals and that the indi-
vidual time courses could be taken as constant over time.
When all the measurements in all the animals at a mag-
netic field strength were then taken together, the standard
deviation at 14.1 T was less than half than that at 9.4 T
(Fig. 2c): [Glyc]9.4 T ¼ 5.8 6 0.9 mM and [Glyc]14.1 T ¼ 6.0
6 0.4 mM. Furthermore, a two-tailed Student’s t-test (a ¼
0.05) resulted in a p ¼ 0.38 probability such that the
means at 9.4 and 14.1 T were equal.
To determine the Glyc C1 T1 relaxation time, an unlo-
calized adiabatic inversion recovery experiment was
used. Fitting the exponential recovery curves was highly
consistent and accurate: R2 ¼ 0.998 on average in n ¼ 2
animals at both field strengths (Fig. 3). The TR and TI
were chosen long enough to allow full relaxation at the
longer TIs, while the adiabatic nature of the pulses
allowed for an almost complete inversion of the magnet-
ization at short TIs despite using a surface coil. The
resulting T1s of 332 6 15 and 521 6 34 ms demonstrate
Table 1
Results of the Glyc and Glc C1 Resonance Measurements at 9.4 and 14.1 T
Substance B0 (T) lw (Hz) SNR T1 (ms) IE (%) Concentration (mM)
Glyc 9.4 48 6 8 7.4 6 1.8 332 6 15 3965 5.8 6 0.9
14.1 53 6 9 12.3 6 0.8 521 6 34 36 64 6.0 6 0.4
Glc 9.4 16.4 6 2.5 1930 6 140 4.3 6 0.4
14.1 23.8 6 2.4 2020 6 180 4.4 6 0.3
All errors are standard deviations of the mean of all animals at a field strength (n ¼ 4 at 9.4 T and n ¼ 3 at 14.1 T).
FIG. 1. A comparison of the spectra obtained at 9.4 T (upper
spectrum) and 14.1 T (lower spectrum) in a volume of interest of
480 mL with TR ¼ 1 and 1 h 9 min acquisition time (4096 repeti-
tions). 15 Hz gaussian line broadening and two times zero filling
have been applied, while for display the spectra are equalized to
the height of the Glc C1b peak. Note the relatively narrow line-
width at 14.1 T, which leaves a wider baseline between the peaks.
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an increase in T1, resulting in a 10% decrease in rSNR
when using a TR of 1 s (11).
DISCUSSION
The Glyc concentrations at both 9.4 and 14.1 T were
consistent with literature (2,9,10). However, at 6.0 6 0.4
mM the time course at 14.1 T had a significantly lower
standard deviation than the 5.8 6 0.9 mM at 9.4 T. The
factors that could contribute to the quantification process
will therefore be discussed in the following paragraphs.
We have demonstrated that the prelabeling method for
Glyc labeling is consistent at different magnet field
strengths and results in readily quantifiable Glyc C1
resonances at both 9.4 and 14.1 T (39 6 5 and 36 6 4%,
respectively), indicating a consistent labeling to the
degree that was observed in previous studies. If this non-
significant difference is taken as an influence on the
observed rSNR (rSNRobs), a correction factor 39/36 ¼
1.08 should be added to obtain the rSNR originating
purely from differences in polarization at the two field
strengths (rSNRtrue). Similarly, rSNRtrue needs to be mul-
tiplied by 1.15/1.16 ¼ 0.99 to correct for the differences
in noise figures of the receive chains.
The ratio of the loaded Q factors of the coils used at
14.1 and 9.4 T was 1.06. As SNR  Q0.5, the rSNRobs
overestimated the rSNRtrue detection by a factor 1.03.
The linewidth (and thus the estimated T2*) of Glyc
also did not change significantly with the field increase,
as expected through the field-indifferent T2 and similar
shimming. The NOE amplification at both field strengths
was the same within experimental error and therefore
did not contribute to the rSNR.
The calculated T1 relaxation time increased propor-
tionally with the magnetic field strength, consistent with
literature (8,11). However, this increase in relaxation
time also implies a relative decrease in rSNR. At the TR
of 1 s, the equation for saturation recovery (S ¼ Sss[1 
exp(TR/T1]) results in 95% of signal recovery for T1 ¼
330 ms, while 85% of the signal recovers when T1 ¼ 520
ms. The increased T1 together with the relatively short
TR, therefore, mean that the rSNRobs underestimated
rSNRtrue by a factor 1.11 due to the incomplete recovery
of the longitudinal magnetization.
With the factors above taken into account, the rSNRtrue
¼ 1.66*1.11*1.08*0.99/1.03 ¼ 1.91, while a factor 1.5
would be expected purely from the magnetic field
strength increase (19). However, it is the rSNRobs that
plays a role in the quantification, indicating that the bet-
ter definition of the baseline at 14.1 T may also contrib-
ute to the 2-fold decrease in standard deviation at 14.1
FIG. 2. Overview of the spread of the glycogen concentration quantification. a: Time courses of the quantified glycogen of the individual
animals (n ¼ 4) at 9.4 T. Each time point represents 4096 localized 13C acquisitions with TR ¼ 1 s in a 480-mL volume of interest in one
animal. b: Similar time courses for the rats (n ¼ 3) at 14.1 T with the same volume of interest and number of scans. An overall smaller
spread of the points can be observed compared to those at 9.4 T. c: Mean and standard deviation of all the individual points of quanti-
fied glycogen concentration in (a) and (b). The P value was calculated through a two-tailed Student’s t-test with a ¼ 0.05.
FIG. 3. Unlocalized glycogen inversion recovery curves at both
field strengths illustrate the difference in T1 relaxation time. The
sequence had a sufficiently long TR (of 5 s) and sufficiently adia-
batic excitation to allow full relaxation and near-full inversion. a:
The fits were highly accurate (R2 ¼ 0.998 for both curves) and
resulted in T1 ¼ 332 6 15 ms at 9.4 T (solid line) and T1 ¼ 521 6
34 ms at 14.1 T (dashed line). To better illustrate the different re-
covery times, completely recovered signal after a 2.0 s TI is dis-
played at a smaller scale. b: Residuals of the fits show a
homogeneous spread, indicating that they mainly consist of noise.
[Color figure can be viewed in the online issue, which is available
at wileyonlinelibrary.com.]
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T. An increased SNR resulted in better baseline defini-
tion, while the increased spectral dispersion resulted in
a larger range for definition of the baseline. The thus
improved overall baseline characterization in concert
with the increased SNR of the resonances likely allowed
a more accurate gaussian peak fitting of the resonances.
This peak fitting then was consistent in all animals and
showed pure-noise residuals.
The Fisher F-test demonstrated that all individual
Glyc time courses were constant over time, as expected
since the animal physiology was kept constant through-
out the experiments. Analogously, as anticipated through
similar physiology and experimental protocols, the Stu-
dent’s t-test at P ¼ 0.38 between the studies at 9.4 and
14.1 T showed no significant difference in the means of
the concentrations.
In conclusion, to our best knowledge, this is the first
report of in vivo 13C-detected MR spectroscopy of brain
glycogen at a field strength higher than 9.4 T. While the
brain glycogen concentration was kept equal and con-
stant at both magnetic field strengths, a clear increase in
SNR and a more dispersed spectrum at 14.1 T offered a
significant increase in quantification accuracy, despite
the increase in T1 relaxation times.
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